keyword
https://read.qxmd.com/read/38643981/nfe2l2-nrf2-deletion-attenuates-tumorigenesis-and-increases-bacterial-diversity-in-a-mouse-model-of-lynch-syndrome
#21
JOURNAL ARTICLE
Felix Haller, Kristine Jimenez, Maximilian Baumgartner, Michaela Lang, Anton Klotz, Manuela Jambrich, Georg Busslinger, Leonhard Müllauer, Vineeta Khare, Christoph Gasche
Lynch syndrome (LS) is the most prevalent heritable form of colorectal cancer (CRC). Its early onset and high lifetime risk for CRC emphasize the necessity for effective chemoprevention. NFE2L2 (NRF2) is often considered a potential druggable target, and many chemopreventive compounds do induce NRF2. However, while NRF2 counteracts oxidative stress, it is also overexpressed in CRC and may promote tumorigenesis. Herein, we evaluated the role of NRF2 in prevention of LS-associated neoplasia. We found an increased levels of NRF2 in intestinal epithelia of mice with intestinal epithelial-specific Msh2 deletion (MSH2ΔIEC) as compared to C57BL/6 (wild type) mice, as well as an increase in downstream NRF2 targets Nqo1 and Gclc...
April 22, 2024: Cancer Prevention Research
https://read.qxmd.com/read/38643763/transcriptomic-profiling-of-lactotroph-pituitary-neuroendocrine-tumors-via-rna-sequencing-and-ingenuity-pathway-analysis
#22
JOURNAL ARTICLE
Yujiro Hattori, Shigeyuki Tahara, Hitoshi Ozawa, Akio Morita, Hirotaka Ishii
INTRODUCTION: Lactotroph pituitary neuroendocrine tumors (PitNETs) are common pituitary tumors, but their underlying molecular mechanisms remain unclear. This study aimed to investigate the transcriptomic landscape of lactotroph PitNETs and identify potential molecular mechanisms and therapeutic targets through RNA sequencing and ingenuity pathway analysis (IPA). METHODS: Lactotroph PitNET tissues from five surgical cases without dopamine agonist treatment underwent RNA sequencing...
April 20, 2024: Neuroendocrinology
https://read.qxmd.com/read/38643748/differential-role-of-glucocorticoid-receptor-based-on-its-cell-type-specific-expression-on-tumor-cells-and-infiltrating-lymphocytes
#23
JOURNAL ARTICLE
V P Snijesh, Vidya P Nimbalkar, Sharada Patil, Savitha Rajarajan, C E Anupama, S Mahalakshmi, Annie Alexander, Ramu Soundharya, Rakesh Ramesh, B S Srinath, Mohit Kumar Jolly, Jyothi S Prabhu
BACKGROUND: The glucocorticoid receptor (GR) is frequently expressed in breast cancer (BC), and its prognostic implications are contingent on estrogen receptor (ER) status. To address conflicting reports and explore therapeutic potential, a GR signature (GRsig) independent of ER status was developed. We also investigated cell type-specific GR protein expression in BC tumor epithelial cells and infiltrating lymphocytes. METHODS: GRsig was derived from Dexamethasone treated cell lines through a bioinformatic pipeline...
April 20, 2024: Translational Oncology
https://read.qxmd.com/read/38643494/ras-raflandscape-in-monoclonal-plasma-cell-conditions
#24
JOURNAL ARTICLE
Anaïs Schavgoulidze, Jill Corre, Mehmet K Samur, Celine Mazzotti, Luka Pavageau, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Margaret Macro, Karim Belhadj, Murielle Roussel, Sabine Brechignac, Lydia Montes, Denis Caillot, Laurent Frenzel, Philippe Rey, Jean Marc Schiano, Thomas Chalopin, Caroline Jacquet, Valentine Richez, Frederique Orsini Piocelle, Jean Fontan, Salomon Manier, Ludovic Martinet, Adam Sciambi, Mohamad Mohty, Hervé Avet-Loiseau
Multiple Myeloma (MM) is characterized by a huge heterogeneity at the molecular level. The RAS/RAF pathway is the most frequently mutated, in about 50% of the patients. However, these mutations are frequently subclonal, suggesting a secondary event. Since these genes are part of our routine next-generation sequencing (NGS) panel, we analyzed >10,000 patients with different plasma cell disorders in order to describe the RAS/RAF landscape. In this large cohort of patients, almost 61% of the patients presented a RAS/RAF mutation at diagnosis or relapse, but much lower frequencies in pre-symptomatic cases...
April 21, 2024: Blood
https://read.qxmd.com/read/38643448/adipose-derived-stem-cells-promote-glycolysis-and-peritoneal-metastasis-via-tgf-%C3%AE-1-smad3-angptl4-axis-in-colorectal-cancer
#25
JOURNAL ARTICLE
Chaojun Zhu, Lan Teng, Yihong Lai, Xingxing Yao, Yuxin Fang, Zihuan Wang, Simin Lin, Haonan Zhang, Qingyuan Li, Ye Li, Jianqun Cai, Yue Zhang, Changjie Wu, Bing Huang, Aimin Li, Side Liu, Qiuhua Lai
Peritoneal metastasis, the third most common metastasis in colorectal cancer (CRC), has a poor prognosis for the rapid progression and limited therapeutic strategy. However, the molecular characteristics and pathogenesis of CRC peritoneal metastasis are poorly understood. Here, we aimed to elucidate the action and mechanism of adipose-derived stem cells (ADSCs), a prominent component of the peritoneal microenvironment, in CRC peritoneal metastasis formation. Database analysis indicated that ADSCs infiltration was increased in CRC peritoneal metastases, and high expression levels of ADSCs marker genes predicted a poor prognosis...
April 21, 2024: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/38643417/synthesis-of-cis-8b-14a-hexahydro-14h-dibenzo-f-h-oxazolo-3-2-b-isoquinolin-14-ones-via-photo-cascade-reaction
#26
JOURNAL ARTICLE
Jingzhi Sui, Yun He, Ding Wang, Tao Wang, Kexin Ren, Yong Liang, Zunting Zhang
A concise method for the synthesis of cis-(8b,14a)-hexahydro-14H-dibenzo[f,h]oxazolo[3,2-b]isoquinolin-14-ones 2 via photo-induced 3-([1,1'-biphenyl]-2-yl)-1-(2-hydroxyethyl)pyridin-2(1H)-ones 1 was developed. Irradiation of 1 in the solution of toluene with a 313 nm UV light in the presence of HCl gave cis-(8b,14a)-9a-α-hexahydro-14H-dibenzo[f,h]oxazolo[3,2-b]isoquinoli n-14-ones and cis-(8b,14a)-9a-β-hexahydro-14H-dibenzo[f,h]oxazolo[3,2-b]isoquinolin-14-ones 2 (2-α and 2-β) in good yields...
April 21, 2024: Molecular Diversity
https://read.qxmd.com/read/38643348/evaluation-of-markers-of-immunity-in-different-metastatic-immune-microenvironments-suggests-more-suppression-within-breast-to-liver-metastases-in-breast-cancer
#27
JOURNAL ARTICLE
Robert Hsu, Batul Al-Zubeidy, Daniel Flores, Ari Nazarian, Aaron Baugh, Edgar Gonzalez, Sofi Castanon, Joanne Xiu, Irene Kang, Darcy Spicer, Heinz Josef Lenz, Lily Dara, Foluso O Ademuyiwa, W Michael Korn, Sheeba Irshad, Isaac S Chan, Evanthia T Roussos Torres
PURPOSE: Programmed death receptor ligand-1 (PD-L1) expression and tumor mutational burden (TMB) are approved screening biomarkers for immune checkpoint inhibition (ICI) in advanced triple negative breast cancer. We examined these biomarkers along with characterization of the tumor microenvironment (TME) between breast tumors (BrTs), axillary metastases (AxMs), liver metastases (LvMs), non-axillary lymph node metastases, and non-liver metastases to determine differences related to site of metastatic disease...
April 20, 2024: Breast Cancer Research and Treatment
https://read.qxmd.com/read/38643173/exosomal-mir-9-5p-derived-from-ipsc-mscs-ameliorates-doxorubicin-induced-cardiomyopathy-by-inhibiting-cardiomyocyte-senescence
#28
JOURNAL ARTICLE
Huifeng Zheng, Xiaoting Liang, Baojuan Liu, Xinran Huang, Ying Shen, Fang Lin, Jiaqi Chen, Xiaoyan Gao, Haiwei He, Weifeng Li, Bei Hu, Xin Li, Yuelin Zhang
Doxorubicin (DOX) is a chemotherapeutic agent widely used for tumor treatment. Nonetheless its clinical application is heavily limited by its cardiotoxicity. There is accumulated evidence that transplantation of mesenchymal stem cell-derived exosomes (MSC-EXOs) can protect against Dox-induced cardiomyopathy (DIC). This study aimed to examine the cardioprotective effects of EXOs isolated from human induced pluripotent stem cell-derived MSCs (iPSC-MSCs) against DIC and explore the potential mechanisms. EXOs were isolated from the cultural supernatant of human BM-MSCs (BM-MSC-EXOs) and iPSC-MSCs (iPSC-MSC-EXOs) by ultracentrifugation...
April 20, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38643058/aml-treatment-conventional-chemotherapy-and-emerging-novel-agents
#29
REVIEW
Mark Forsberg, Marina Konopleva
Acute myeloid leukemia (AML) is driven by complex mutations and cytogenetic abnormalities with profound tumoral heterogeneity, making it challenging to treat. Ten years ago, the 5-year survival rate of patients with AML was only 29% with conventional chemotherapy and stem cell transplantation. All attempts to improve conventional therapy over the previous 40 years had failed. Now, new genomic, immunological, and molecular insights have led to a renaissance in AML therapy. Improvements to standard chemotherapy and a wave of new targeted therapies have been developed...
April 19, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38642856/glyr1-transcriptionally-regulates-per3-expression-to-promote-the-proliferation-and-migration-of-multiple-myeloma
#30
JOURNAL ARTICLE
Xiao Yan, Kaihong Xu, Zhijuan Xu, Cong Shi, Binbin Lai, Hao Wu, Shujun Yang, Lixia Sheng, Keting Wang, Yuhan Zheng, Guifang Ouyang, Di Yang
Period circadian regulator 3 (PER3) functions as a tumor suppressor in various cancers. However, the role of PER3 in multiple myeloma (MM) has not been reported yet. Through this study, we aimed to investigate the potential role of PER3 in MM and the underlying mechanisms. RT-qPCR and western blotting were used to determine the mRNA and protein expression levels of PER3. Glyoxylate reductase 1 homolog (GLYR1) was predicted to be a transcription factor of PER3. The binding sites of GLYR1 on the promoter region of PER3 were analyzed using UCSC and confirmed using luciferase and chromatin immunoprecipitation assays...
April 18, 2024: Genomics
https://read.qxmd.com/read/38642609/tumor-associated-macrophage-induced-circmrck%C3%AE-encodes-a-peptide-to-promote-glycolysis-and-progression-in-hepatocellular-carcinoma
#31
JOURNAL ARTICLE
Songyang Yu, Sheng Su, Pengcheng Wang, Jia Li, Changzhou Chen, Haoyang Xin, Yu Gong, Hezhi Wang, Xinming Ye, Li Mao, Zhengjun Zhou, Shaolai Zhou, Zhiqiang Hu, Xiaowu Huang
The tumor-associated macrophages (TAMs) play multifaceted roles in the progression of hepatocellular carcinoma (HCC). However, the involvement of circular RNAs in the interplay between TAMs and HCC remains unclear. Based on Transwell co-culturing and circular RNA sequencing, this study revealed that TAMs enhanced tumor glycolysis and progression by upregulating circMRCKα in HCC cells. Patients with HCC who exhibited elevated circMRCKα levels presented significantly reduced overall survival and greater cumulative recurrence...
April 18, 2024: Cancer Letters
https://read.qxmd.com/read/38642165/nanopore-sequencing-from-formalin-fixed-paraffin-embedded-specimens-for-copy-number-profiling-and-methylation-based-cns-tumor-classification
#32
JOURNAL ARTICLE
Ann-Kristin Afflerbach, Anne Albers, Anton Appelt, Leonille Schweizer, Werner Paulus, Michael Bockmayr, Ulrich Schüller, Christian Thomas
No abstract text is available yet for this article.
April 20, 2024: Acta Neuropathologica
https://read.qxmd.com/read/38642130/genomic-characterization-and-detection-of-potential-therapeutic-targets-for-peritoneal-mesothelioma-in-current-practice
#33
JOURNAL ARTICLE
Job P van Kooten, Michelle V Dietz, Hendrikus Jan Dubbink, Cornelis Verhoef, Joachim G J V Aerts, Eva V E Madsen, Jan H von der Thüsen
Peritoneal mesothelioma (PeM) is an aggressive tumor with limited treatment options. The current study aimed to evaluate the value of next generation sequencing (NGS) of PeM samples in current practice. Foundation Medicine F1CDx NGS was performed on 20 tumor samples. This platform assesses 360 commonly somatically mutated genes in solid tumors and provides a genomic signature. Based on the detected mutations, potentially effective targeted therapies were identified. NGS was successful in 19 cases. Tumor mutational burden (TMB) was low in 10 cases, and 11 cases were microsatellite stable...
April 20, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38641828/n6-methyladenosine-modified-circslco1b3-promotes-intrahepatic-cholangiocarcinoma-progression-via-regulating-hoxc8-and-pd-l1
#34
JOURNAL ARTICLE
Jing Li, Xiaohong Xu, Kaihao Xu, Xueliang Zhou, Kunpeng Wu, Yuan Yao, Zaoqu Liu, Chen Chen, Ling Wang, Zhenqiang Sun, Dechao Jiao, Xinwei Han
BACKGROUND: Refractoriness to surgical resection and chemotherapy makes intrahepatic cholangiocarcinoma (ICC) a fatal cancer of the digestive system with high mortality and poor prognosis. Important function invests circRNAs with tremendous potential in biomarkers and therapeutic targets. Nevertheless, it is still unknown how circRNAs contribute to the evolution of ICC. METHODS: CircRNAs in paired ICC and adjacent tissues were screened by circRNAs sequencing. To explore the impact of circRNAs on ICC development, experiments involving gain and loss of function were conducted...
April 20, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38641815/unveiling-the-gastric-microbiota-implications-for-gastric-carcinogenesis-immune-responses-and-clinical-prospects
#35
REVIEW
Zhiyi Liu, Dachuan Zhang, Siyu Chen
High-throughput sequencing has ushered in a paradigm shift in gastric microbiota, breaking the stereotype that the stomach is hostile to microorganisms beyond H. pylori. Recent attention directed toward the composition and functionality of this 'community' has shed light on its potential relevance in cancer. The microbial composition in the stomach of health displays host specificity which changes throughout a person's lifespan and is subject to both external and internal factors. Distinctive alterations in gastric microbiome signature are discernible at different stages of gastric precancerous lesions and malignancy...
April 19, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38641511/development-of-new-techniques-and-clinical-applications-of-liquid-biopsy-in-lung-cancer-management
#36
REVIEW
Kezhong Chen, Yue He, Wenxiang Wang, Xiaoqiu Yuan, David P Carbone, Fan Yang
Lung cancer is an exceedingly malignant tumor reported as having the highest morbidity and mortality of any cancer worldwide, thus posing a great threat to global health. Despite the growing demand for precision medicine, current methods for early clinical detection, treatment and prognosis monitoring in lung cancer are hampered by certain bottlenecks. Studies have found that during the formation and development of a tumor, molecular substances carrying tumor-related genetic information can be released into body fluids...
April 1, 2024: Science Bulletin
https://read.qxmd.com/read/38641019/a-novel-approach-to-ph-responsive-targeted-cancer-therapy-inhibition-of-fadu-cancer-cell-proliferation-with-a-ph-low-insertion-peptide-conjugated-dgat1-inhibitor
#37
JOURNAL ARTICLE
Marine Deskeuvre, Junjie Lan, Joris Messens, Olivier Riant, Olivier Feron, Raphaël Frédérick
Targeting enzymes involved in lipid metabolism is increasingly recognized as a promising anticancer strategy. Efficient inhibition of diacylglycerol O-transferase 1 (DGAT1) can block fatty acid (FA) storage. This, in turn, triggers an increase in free polyunsaturated FA concentration, leading to peroxidation and ferroptosis. In this study, we report the development of a pH-sensitive peptide (pHLIP)-drug conjugate designed to selectively deliver DGAT1 inhibitors to cancer cells nested within the acidic microenvironment of tumors...
April 17, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38640982/pfkfb3-regulates-breast-cancer-tumorigenesis-and-fulvestrant-sensitivity-by-affecting-er%C3%AE-stability
#38
JOURNAL ARTICLE
Wenzhi Jia, Qianyun Wu, Mengqin Shen, Xiaofeng Yu, Shuxian An, Li Zhao, Gang Huang, Jianjun Liu
Estrogen receptor alpha (ERα) is expressed in approximately 70% of breast cancer cases and determines the sensitivity and effectiveness of endocrine therapy. 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase3 (PFKFB3) is a glycolytic enzyme that is highly expressed in a great many human tumors, and recent studies have shown that it plays a significant role in improving drug sensitivity. However, the role of PFKFB3 in regulating ERα expression and the underlying mechanism remains unclear. Here, we find by using immunohistochemistry (IHC) that PFKFB3 is elevated in ER-positive breast cancer and high expression of PFKFB3 resulted in a worse prognosis...
April 17, 2024: Cellular Signalling
https://read.qxmd.com/read/38640981/stat1-mediated-downregulation-of-the-tumor-suppressor-gene-pdcd4-is-driven-by-the-atypical-cadherin-fat1-in-glioblastoma
#39
JOURNAL ARTICLE
Tipu Khan, Mariyam Almas, Nargis Malik, Akansha Jalota, Shaifali Sharma, Sk Asif Ali, Kalpana Luthra, Vaishali Suri, Ashish Suri, Soumen Basak, Pankaj Seth, Kunzang Chosdol, Subrata Sinha
STAT1 (Signal Transducer and Activator of Transcription 1), belongs to the STAT protein family, essential for cytokine signaling. Ithas been reported to have either context dependent oncogenic or tumor suppressor roles in different tumors. Earlier, we demonstrated that Glioblastoma multiforme (GBMs) overexpressing FAT1, an atypical cadherin, had poorer outcomes. Overexpressed FAT1 promotes pro-tumorigenic inflammation, migration/invasion by downregulating tumor suppressor gene, PDCD4. Here, we demonstrate that STAT1 is a novel mediator downstream to FAT1, in downregulating PDCD4 in GBMs...
April 17, 2024: Cellular Signalling
https://read.qxmd.com/read/38640858/ginsenoside-rg5-inhibits-glioblastoma-by-activating-ferroptosis-via-nr3c1-hspb1-ncoa4
#40
JOURNAL ARTICLE
Guoqing Zhang, Jinpeng Hu, Ao Li, Haiying Zhang, Zhengting Guo, Xinqiao Li, Zinan You, Yongfeng Wang, Zhitao Jing
BACKGROUND: The utilization of Chinese medicine as an adjunctive therapy for cancer has recently gained significant attention. Ferroptosis, a newly regulated cell death process depending on the ferrous ions, has been proved to be participated in glioma stem cells inactivation. PURPOSE: We aim to study whether ginsenoside Rg5 exerted inhibitory effects on crucial aspects of glioma stem cells, including cell viability, tumor initiation, invasion, self-renewal ability, neurosphere formation, and stemness...
April 12, 2024: Phytomedicine
keyword
keyword
108479
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.